IVA Chart
See on advanced chart >
About
Inventiva S.A. was founded in 2011 and incorporated in 2016. The company is a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis, or NASH,...
Read More
- HighlightA clinical-stage biopharmaceutical company that developing oral small molecule therapies for non-alcoholic steatohepatitis
- ExchangeNASDAQ
- Listing Date07/10/2020
- Established DateInvalid Date
- Full-time Employees120
- Address50 rue de Dijon 21121 Daix France
- Tel33-3-80447500
- Website
- Fiscal Year End Date12/31
- Security TypeAmerican Depositary Receipt (Common Stock)
Industry
Biotechnology